Comments
Loading...

Regeneron Pharmaceuticals

REGNNASDAQ
$1069.74
00.00%
Pre-Market: 5:08 PM EDT
15 minutes delayed
Q2 2024 Earnings in 9 days from now on Thu Aug 1st, before the market open
62.5%
Overview Rating
Good

Unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Click Here
Technicals Analysis
100
0100
Financials Analysis
40
0100
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trends and Forecast
3
Mar
1
2
1
Apr
1
1
May
4
Jun
3
1
Jul
Buy
Hold
Sell
Strong Sell
Analyst Rating and Forecast
12345
3.9
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Regeneron Pharmaceuticals, Inc.
Sector
Health Care
Industry
Biotechnology
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, c...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
REGN
LEGN

FAQ

Q

How do I buy Regeneron Pharmaceuticals (REGN) stock?

A

You can purchase shares of Regeneron Pharmaceuticals (NASDAQ:REGN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Regeneron Pharmaceuticals (REGN) competitors?

Q

What is the target price for Regeneron Pharmaceuticals (REGN) stock?

A

There is no analysis for Regeneron Pharmaceuticals.

Q

What is the forecast for Regeneron Pharmaceuticals (REGN) stock?

A

Regeneron Pharmaceuticals has a consensus price target of $1022.76.

Q

Current stock price for Regeneron Pharmaceuticals (REGN)?

A

The stock price for Regeneron Pharmaceuticals (NASDAQ: REGN) is $1069.74 last updated July 22, 2024 at 5:08 PM EDT.

Q

Does Regeneron Pharmaceuticals (REGN) pay a dividend?

A

There are no upcoming dividends for Regeneron Pharmaceuticals.

Q

When is Regeneron Pharmaceuticals (NASDAQ:REGN) reporting earnings?

A

Regeneron Pharmaceuticals’s Q2 earnings are confirmed for Thursday, August 1, 2024.

Q

Is Regeneron Pharmaceuticals (REGN) going to split?

A

There is no upcoming split for Regeneron Pharmaceuticals.

Q

What sector and industry does Regeneron Pharmaceuticals (REGN) operate in?

A

Regeneron Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch